Chromocell Announces Amendment to Stock Repurchase Plan

Stock Information for Channel Therapeutics Corporation

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Channel Therapeutics Corporation

Chromocell Announces Name Change to "Channel Therapeutics Corporation" and Provides Therapeutic Program Updates
Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain
Chromocell to Present at Upcoming Fall Investor Conferences
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
Chromocell to Participate in Life Sciences Investor Forum September 19th
Chromocell to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Chromocell to Participate in the Virtual Investor Lunch Break Series

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.